A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 7, Issue 1, 2008, Pages 60-67

  Papas, Konstantinos A ^c   Sontag, Marci K ^a,b   Pardee, Churee ^a   Sokol, Ronald J ^a   Sagel, Scott D ^a   Accurso, Frank J ^a   Wagener, Jeffrey S ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Yasoo Health   (United States)

Author keywords

Antioxidant; Beta carotene; Coenzyme Q10; Cystic fibrosis; Gamma tocopherol; Induced sputum; Inflammatory markers; Malabsorption; Pancretic insufficiency

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; AZITHROMYCIN; BETA CAROTENE; BIOLOGICAL MARKER; CIPROFLOXACIN; COLECALCIFEROL; COTRIMOXAZOLE; DOXYCYCLINE; ELASTASE; GAMMA TOCOPHEROL; INTERLEUKIN 8; ITRACONAZOLE; MULTIVITAMIN; MYELOPEROXIDASE; PHYTOMENADIONE; RETINOL; TOBRAMYCIN; TOCOPHEROL; UBIDECARENONE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BLOOD CELL COUNT; BLOOD SAMPLING; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; INFLAMMATION; LABORATORY TEST; LUNG FUNCTION; MICELLE; NAUSEA; NEUTROPHIL; NUTRIENT; PILOT STUDY; SCHOOL CHILD; SIDE EFFECT; SPIROMETRY; SPUTUM ANALYSIS; STOMACH DISEASE;

ADOLESCENT; ADULT; ANTIOXIDANTS; BETA CAROTENE; BIOLOGICAL AVAILABILITY; CHILD; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; EXOCRINE PANCREATIC INSUFFICIENCY; GAMMA-TOCOPHEROL; HUMANS; INTERLEUKIN-8; MICELLES; MIDDLE AGED; PILOT PROJECTS; SPUTUM; UBIQUINONE;

EID: 38049017587     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2007.05.001     Document Type: Article

References (29)

1. Sokol R.J., and Papas A.M. Antioxidants and neurological diseases. In: Papas A.M. (Ed). Antioxidant status, diet, nutrition and health (1998), CRC Press, Boca Raton 567-590
2. Erdman S.H. Nutritional imperatives in cystic fibrosis therapy. Pediatr Ann 28 (1999) 129-136
3. Kalivianakis M., Minich D.M., Bijleveld C.M., et al. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69 (1999) 127-134
4. Feranchak A.P., Sontag M.K., Wagener J.S., Hammond K.B., Accurso F.J., and Sokol R.J. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 135 5 (1999) 601-610
5. Sokol R.J., Osberg I., Sontag M.K., and Wagener J.S. Reduced serum coenzyme Q10 concentrations in children with cystic fibrosis. North American meeting on cystic fibrosis. Pediatr Pulmonol 36 S25 (2003) 8-376
6. Papas KA, Kalbfleisch JH, Mohon RT. Bioavailability of a novel water-soluble vitamin E formulation in malabsorbing patients. Dig. Dis. Sci. in press.
7. Cantin A.M., White T.B., Cross C.E., Forman H.J., Sokol R.J., and Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF Antioxidant Workshop, Bethesda, Maryland, November 11-12, 2003. Free Radic Biol Med 42 1 (2007) 15-31
8. Oudshoorn J.H., Lecluse A.L., van den Berg R., Vaes W.H., van der Laag J., and Houwen R.H. Decreased coenzyme Q10 concentration in plasma of children with cystic fibrosis. J Pediatr Gastroenterol Nutr 43 5 (2006) 646-650
9. Lagrange-Puget M., Durieu I., Ecochard R., et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol 38 1 (2004) 43-49
10. Sagel S.D., and Accurso F.J. Monitoring inflammation in CF. Cytokines. Clin Rev Allergy Immunol 23 1 (2002) 41-57
11. Winklhofer-Roob B.M., Puhl H., Khoschsorur G., van't Hof M.A., Esterbauer H., and Shmerling D.H. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. Free Radic Biol Med 18 (1995) 849-859
12. Rust P., Eichler I., Renner S., and Elmadfa I. Effects of long-term oral beta-carotene supplementation on lipid peroxidation inpatients with cystic fibrosis. Int J Vitam Nutr Res 68 (1998) 83-87
13. Winklhofer-Roob B.M., van't Hof M.A., and Shmerling D.H. Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study. Acta Paediatr 84 10 (1995) 1132-1136
14. Lepage G., Champagne J., and Ronco N. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 64 (1996) 87-93
15. Brown R.K., Wyatt H., Price J.F., and Kelly F.J. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 9 (1996) 334-339
16. Wood L.G., Fitzgerald D.A., Lee A.K., and Garg M.L. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 77 1 (2003) 150-159
17. Renner S., Rath R., Rust P., et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 56 1 (2001) 48-52
18. Sagel S.D., Kapsnew R., Osberg I., Sontag M.K., and Accurso F.J. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med 164 (2001) 1425-1431
19. Burns J.L., Emerson J., Stapp J.R., et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 27 1 (1998) 158-163
20. Kaplan L., Miller J.A., Stein E.A., and Stampfer M.J. Simultaneous, high-performance liquid chromatographic analysis of retinol, tocopherols, lycopene, and alpha- and beta-carotene in serum and plasma. Methods Enzymol 189 (1990) 155-167
21. Johnson E.J., and Russell R.M. Distribution of orally administered beta-carotene among lipoproteins in healthy men. Am J Clin Nutr 56 1 (1992) 128-135
22. Homnick D.N., Spillers C.R., Cox S.R., et al. Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis. J Pediatr 127 3 (1995) 491-494
23. Cobanoglu N., Ozcelik U., Gocmen A., Kiper N., and Dogru D. Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatr 91 7 (2002) 793-798
24. Winklhofer-Roob B.M. Vitamin E supplementation in cystic fibrosis. J Pediatr Gastroenterol Nutr 25 1 (1997) 120-122
25. Huang S.H., Schall J.I., Zemel B.S., and Stallings V.A. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr 148 4 (2006) 556-559
26. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., and Ames B.N. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A 94 (1997) 3217-3222
27. Singh U., Devaraj S., and Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 25 (2005) 151-174 [Review]
28. Kettle A.J., Chan T., Osberg I., et al. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 170 12 (2004) 1317-1323
29. Starosta V., Rietschel E., Paul K., Baumann U., and Griese M. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 129 2 (2006) 431-437